,reactionoutcome,reactionmeddraversionpt,reactionmeddrapt,safetyreportid
0,1,22.0,Urinary retention,16198508
1,1,22.0,Dysuria,16198508
0,3,22.1,Pyrexia,16198524
1,1,22.1,Cellulitis,16198524
2,1,22.1,Constipation,16198524
3,1,22.1,Haemoptysis,16198524
0,6,22.0,Haematochezia,16198525
1,6,22.0,Abdominal discomfort,16198525
2,6,22.0,Haematotoxicity,16198525
3,6,22.0,Pulmonary fibrosis,16198525
4,6,22.0,Gastroenteritis,16198525
5,6,22.0,Rash,16198525
6,6,22.0,Skin reaction,16198525
7,6,22.0,Pruritus,16198525
8,6,22.0,Cystic lung disease,16198525
9,6,22.0,Defaecation disorder,16198525
10,6,22.0,Neuropathy peripheral,16198525
11,6,22.0,Vomiting,16198525
12,6,22.0,Erythema,16198525
13,6,22.0,Weight decreased,16198525
14,6,22.0,Nausea,16198525
15,6,22.0,Asthenia,16198525
16,1,22.0,Pleural effusion,16198525
0,5,22.0,Death,16198529
1,6,22.0,Pneumonitis,16198529
0,3,22.0,Acute kidney injury,16198546
0,2,22.0,Enteritis,16198597
0,6,22.0,Lung hernia,16198618
1,6,22.0,Dry mouth,16198618
2,6,22.0,Stomatitis,16198618
3,6,22.0,Dysphonia,16198618
0,6,22.0,Cerebrovascular accident,16198619
1,6,22.0,Drug ineffective,16198619
2,6,22.0,Coronary artery occlusion,16198619
0,6,22.0,Diarrhoea,16198622
0,6,22.1,Dizziness,16198662
1,1,22.1,Anaemia,16198662
2,6,22.1,Palmar-plantar erythrodysaesthesia syndrome,16198662
3,6,22.1,Weight decreased,16198662
4,3,22.1,Fatigue,16198662
5,1,22.1,Taste disorder,16198662
6,6,22.1,Skin fissures,16198662
0,1,22.1,Stomatitis,16198663
1,1,22.1,Borrelia infection,16198663
2,3,22.1,Fatigue,16198663
3,4,22.1,Urinary tract disorder,16198663
4,1,22.1,Lacrimation increased,16198663
5,3,22.1,Anaemia,16198663
6,1,22.1,Depression,16198663
7,1,22.1,Back pain,16198663
8,6,22.1,Tachycardia,16198663
9,1,22.1,Cystitis noninfective,16198663
10,1,22.1,Nausea,16198663
11,1,22.1,Diarrhoea,16198663
12,1,22.1,Influenza like illness,16198663
13,3,22.1,Lymphoedema,16198663
14,1,22.1,Dyspepsia,16198663
15,1,22.1,Urinary tract infection,16198663
16,3,22.1,Peripheral sensory neuropathy,16198663
17,1,22.1,Dysuria,16198663
18,1,22.1,Dyshidrotic eczema,16198663
19,6,22.1,Dyspnoea,16198663
20,1,22.1,Pain in extremity,16198663
21,1,22.1,Erysipelas,16198663
22,1,22.1,Sinus tachycardia,16198663
23,3,22.1,Skin disorder,16198663
24,4,22.1,Renal disorder,16198663
25,3,22.1,Dysphagia,16198663
26,1,22.1,Dysgeusia,16198663
27,1,22.1,Paronychia,16198663
28,1,22.1,Pulmonary embolism,16198663
0,6,22.0,Weight decreased,16198684
1,6,22.0,Nausea,16198684
2,6,22.0,Abdominal discomfort,16198684
3,6,22.0,Vomiting,16198684
4,6,22.0,Hyperkalaemia,16198684
5,6,22.0,Decreased appetite,16198684
6,6,22.0,Flatulence,16198684
0,2,22.0,Dyspnoea,16198711
1,2,22.0,Amaurosis,16198711
2,6,22.0,Heart rate decreased,16198711
0,1,22.0,Acute myeloid leukaemia,16198712
1,1,22.0,Second primary malignancy,16198712
0,2,22.0,Palmar-plantar erythrodysaesthesia syndrome,16198713
1,3,22.0,Neutropenia,16198713
2,3,22.0,Haemorrhage,16198713
3,1,22.0,Thrombocytopenia,16198713
0,5,22.0,Death,16198740
0,1,22.0,Dyspepsia,16198767
1,1,22.0,Abdominal pain upper,16198767
2,1,22.0,Hyperhidrosis,16198767
3,1,22.0,Condition aggravated,16198767
0,6,22.0,Squamous cell carcinoma,16198793
1,6,22.0,Lichen planus,16198793
0,6,22.0,Bladder cancer recurrent,16198807
0,5,22.1,Disseminated intravascular coagulation,16198818
1,3,22.1,Enterocolitis,16198818
2,5,22.1,Malignant neoplasm progression,16198818
0,6,22.0,Critical illness,16198819
0,5,22.0,Lung disorder,16198826
0,1,22.0,Disease recurrence,16198854
1,1,22.0,Ureteric obstruction,16198854
2,1,22.0,Febrile neutropenia,16198854
0,3,22.0,Angina pectoris,16198933
1,3,22.0,Hepatic function abnormal,16198933
2,3,22.0,Neutrophil count decreased,16198933
0,3,22.0,Glomerulonephropathy,16198968
1,3,22.0,Oedema peripheral,16198968
2,3,22.0,Weight increased,16198968
0,6,22.0,Tumour pseudoprogression,16198994
1,6,22.0,Pulmonary mass,16198994
0,5,22.0,Myocardial infarction,16199021
0,4,22.0,Acute myocardial infarction,16199047
1,4,22.0,Vascular stent insertion,16199047
0,6,22.0,Stomatitis,16199048
1,1,22.0,Influenza,16199048
2,6,22.0,Headache,16199048
3,6,22.0,Fatigue,16199048
0,6,22.1,Intentional product use issue,16199109
1,6,22.1,Adverse event,16199109
0,6,22.0,Somnolence,16199119
1,6,22.0,Decreased appetite,16199119
2,3,22.0,Vomiting,16199119
3,5,22.0,Death,16199119
4,2,22.0,Blood iron decreased,16199119
5,6,22.0,White blood cell count decreased,16199119
6,3,22.0,Fatigue,16199119
7,6,22.0,Diarrhoea,16199119
8,3,22.0,Nausea,16199119
9,3,22.0,Asthenia,16199119
10,6,22.0,Headache,16199119
11,6,22.0,Blood glucose increased,16199119
0,5,22.1,Sepsis,16199120
0,6,22.1,Blood pressure decreased,16199142
1,6,22.1,Product dose omission,16199142
2,2,22.1,Fatigue,16199142
3,2,22.1,White blood cell count decreased,16199142
4,6,22.1,Fluid retention,16199142
5,2,22.1,Onychoclasis,16199142
6,2,22.1,Dry skin,16199142
7,2,22.1,Blood sodium increased,16199142
8,6,22.1,Chest pain,16199142
9,6,22.1,Nausea,16199142
10,2,22.1,Diarrhoea,16199142
11,6,22.1,Arthralgia,16199142
12,6,22.1,Hyperhidrosis,16199142
13,6,22.1,Neoplasm progression,16199142
14,6,22.1,Blister,16199142
0,5,22.0,Malignant neoplasm progression,16199157
0,6,22.0,Varices oesophageal,16199161
1,6,22.0,Non-cirrhotic portal hypertension,16199161
2,6,22.0,Splenomegaly,16199161
3,6,22.0,Haematemesis,16199161
0,6,22.0,Oesophageal haemorrhage,16199163
1,6,22.0,Splenomegaly,16199163
2,6,22.0,Hepatic lesion,16199163
3,6,22.0,Varices oesophageal,16199163
4,6,22.0,Non-cirrhotic portal hypertension,16199163
0,1,22.0,Chills,16199179
1,1,22.0,Abdominal pain upper,16199179
2,1,22.0,Peptic ulcer,16199179
3,1,22.0,Hyperhidrosis,16199179
0,6,22.0,Hepatotoxicity,16199274
1,6,22.0,Cholecystitis,16199274
0,6,22.0,Rash,16199289
0,6,22.0,Dyspnoea,16199298
0,1,22.0,Neutrophil count decreased,16199331
0,6,22.0,Thrombocytopenia,16199350
0,6,22.0,Colon cancer recurrent,16199386
0,3,22.0,Colorectal cancer recurrent,16199389
0,1,22.1,Tumour necrosis,16199425
1,1,22.1,Hypercalcaemia,16199425
2,1,22.1,Pneumonia,16199425
3,1,22.1,Pyrexia,16199425
4,1,22.1,Anaemia,16199425
0,3,22.0,Thyroid function test abnormal,16199430
1,3,22.0,Night sweats,16199430
2,3,22.0,Malignant neoplasm progression,16199430
3,3,22.0,Hyperhidrosis,16199430
0,2,22.0,Hypertransaminasaemia,16199486
0,6,22.0,Tonsillar disorder,16199635
1,6,22.0,Nasal disorder,16199635
2,6,22.0,Lower limb fracture,16199635
0,4,22.0,Swollen tongue,16199678
1,3,22.0,Cough,16199678
0,6,22.0,Ejection fraction decreased,16199738
1,6,22.0,Peripheral swelling,16199738
2,6,22.0,Neoplasm progression,16199738
3,1,22.0,Pruritus,16199738
4,6,22.0,Hypoaesthesia,16199738
5,6,22.0,Oedema peripheral,16199738
6,6,22.0,Hepatomegaly,16199738
7,6,22.0,Erythema,16199738
8,6,22.0,Polyneuropathy,16199738
0,1,22.1,Cutaneous sarcoidosis,16199766
1,1,22.1,Epiglottic oedema,16199766
0,3,22.0,Constipation,16199783
1,3,22.0,Colitis,16199783
2,3,22.0,Dysarthria,16199783
3,3,22.0,Night sweats,16199783
4,3,22.0,Alopecia,16199783
5,3,22.0,Heart rate increased,16199783
6,3,22.0,Weight decreased,16199783
0,5,22.0,Death,16199799
0,3,22.1,Bone pain,16199805
1,6,22.1,Tooth loss,16199805
2,6,22.1,Dry mouth,16199805
3,6,22.1,Rash,16199805
0,6,22.0,Anxiety,16199835
1,3,22.0,Madarosis,16199835
2,6,22.0,Depression,16199835
3,3,22.0,Alopecia,16199835
0,1,22.0,Anaemia,16199872
1,5,22.0,Non-small cell lung cancer,16199872
0,1,22.0,Arthralgia,16199891
1,1,22.0,Nausea,16199891
2,1,22.0,Abdominal discomfort,16199891
3,1,22.0,Decreased appetite,16199891
4,3,22.0,Gynaecomastia,16199891
5,3,22.0,Hot flush,16199891
0,6,22.1,Malignant neoplasm progression,16199894
1,6,22.1,Rash pustular,16199894
2,6,22.1,Disease progression,16199894
3,6,22.1,Carcinoembryonic antigen increased,16199894
4,6,22.1,Hepatic necrosis,16199894
5,6,22.1,Metastases to liver,16199894
6,6,22.1,Hepatic cancer,16199894
7,1,22.1,Hypertension,16199894
8,6,22.1,Gastrointestinal toxicity,16199894
9,6,22.1,PIK3CA-activated mutation,16199894
10,6,22.1,Carbohydrate antigen 19-9 increased,16199894
0,6,22.0,Pulmonary embolism,16199906
1,1,22.0,Acute kidney injury,16199906
2,6,22.0,Pyrexia,16199906
3,1,22.0,Tubulointerstitial nephritis,16199906
4,2,22.0,Malignant neoplasm progression,16199906
5,6,22.0,Sarcoidosis,16199906
0,1,22.0,Agranulocytosis,16199929
1,1,22.0,Folliculitis,16199929
2,1,22.0,Pyrexia,16199929
3,1,22.0,Diarrhoea,16199929
4,1,22.0,Abdominal pain,16199929
5,1,22.0,Chills,16199929
0,6,22.0,Blood glucose increased,16199981
0,1,22.0,Polycystic ovaries,16200020
1,1,22.0,Neutropenia,16200020
2,1,22.0,Hypothyroidism,16200020
0,6,22.0,Off label use,16200037
0,6,22.0,Off label use,16200050
0,6,22.1,Pain,16200068
1,6,22.1,Impaired quality of life,16200068
2,6,22.1,Anxiety,16200068
3,6,22.1,Emotional distress,16200068
4,6,22.1,Psychological trauma,16200068
5,2,22.1,Alopecia,16200068
0,6,22.0,Psychological trauma,16200076
1,6,22.0,Emotional distress,16200076
2,6,22.0,Impaired quality of life,16200076
3,2,22.0,Alopecia,16200076
4,6,22.0,Pain,16200076
5,6,22.0,Anxiety,16200076
0,3,22.0,Alopecia,16200081
1,6,22.0,Emotional distress,16200081
2,6,22.0,Impaired quality of life,16200081
3,6,22.0,Pain,16200081
4,6,22.0,Psychological trauma,16200081
5,6,22.0,Anxiety,16200081
0,6,22.0,Emotional distress,16200086
1,2,22.0,Alopecia,16200086
2,6,22.0,Pain,16200086
3,6,22.0,Anxiety,16200086
4,6,22.0,Impaired quality of life,16200086
0,2,22.0,Alopecia,16200087
1,6,22.0,Psychological trauma,16200087
0,2,22.0,Alopecia,16200089
1,6,22.0,Psychological trauma,16200089
0,6,22.1,Psychological trauma,16200092
1,6,22.1,Anxiety,16200092
2,6,22.1,Emotional distress,16200092
3,6,22.1,Pain,16200092
4,6,22.1,Impaired quality of life,16200092
5,2,22.1,Alopecia,16200092
0,1,22.0,Malaise,16200094
1,1,22.0,Blood magnesium decreased,16200094
2,1,22.0,Body temperature decreased,16200094
0,1,22.0,Vomiting,16200095
1,6,22.0,Product use issue,16200095
2,6,22.0,Pain in extremity,16200095
3,1,22.0,Mucosal inflammation,16200095
4,1,22.0,C-reactive protein increased,16200095
5,6,22.0,Disease progression,16200095
6,3,22.0,Arthralgia,16200095
7,1,22.0,Wound,16200095
8,1,22.0,Diarrhoea,16200095
9,1,22.0,Bone pain,16200095
0,6,22.0,Neutropenia,16200221
1,6,22.0,Leukopenia,16200221
0,6,22.0,Gastrointestinal toxicity,16200267
1,6,22.0,PIK3CA-activated mutation,16200267
2,2,22.0,Hypertension,16200267
3,6,22.0,Metastases to liver,16200267
4,2,22.0,Carbohydrate antigen 19-9 increased,16200267
5,6,22.0,Rash pustular,16200267
6,2,22.0,Carcinoembryonic antigen increased,16200267
7,6,22.0,Hepatic necrosis,16200267
0,3,22.0,Cholangitis,16200277
1,3,22.0,Hepatitis cholestatic,16200277
0,6,22.0,Adverse event,16200284
0,6,22.0,Pneumonia,16200326
1,6,22.0,Malnutrition,16200326
2,5,22.0,Death,16200326
3,3,22.0,Hepatic function abnormal,16200326
0,3,22.0,Acute myeloid leukaemia,16200371
0,6,22.0,Malignant neoplasm progression,16200384
1,6,22.0,Breast cancer metastatic,16200384
0,6,22.0,Off label use,16200393
0,5,22.0,Death,16200440
0,1,22.0,Neutropenia,16200468
1,2,22.0,Hepatotoxicity,16200468
2,3,22.0,Aspartate aminotransferase increased,16200468
3,3,22.0,Alanine aminotransferase increased,16200468
4,3,22.0,Blood lactate dehydrogenase increased,16200468
5,6,22.0,Arthralgia,16200468
0,1,22.0,Lactic acidosis,16200469
1,1,22.0,Diarrhoea,16200469
2,2,22.0,Acute kidney injury,16200469
0,6,22.0,Off label use,16200498
0,6,22.0,Rash macular,16200534
0,5,22.1,Suspected counterfeit product,16200610
1,5,22.1,Death,16200610
0,6,22.0,Off label use,16200645
0,6,22.0,Off label use,16200647
0,6,22.0,Off label use,16200667
0,2,22.0,Dizziness,16200680
1,3,22.0,Rash,16200680
2,3,22.0,Muscle spasms,16200680
3,6,22.0,Myalgia,16200680
0,6,22.0,Alanine aminotransferase increased,16200724
1,6,22.0,Aspartate aminotransferase increased,16200724
2,3,22.0,Hepatic function abnormal,16200724
0,6,22.0,Weight decreased,16200730
1,2,22.0,Bronchitis,16200730
2,6,22.0,Gait disturbance,16200730
3,3,22.0,Pain in extremity,16200730
4,6,22.0,Asthenia,16200730
5,3,22.0,Arthralgia,16200730
6,6,22.0,Tremor,16200730
7,3,22.0,Bone pain,16200730
0,6,22.0,Off label use,16200779
0,3,22.0,Alopecia,16200930
0,3,22.0,Product prescribing error,16200999
1,3,22.0,Product use in unapproved indication,16200999
2,3,22.0,Sleep disorder,16200999
0,1,22.0,Confusional state,16201023
1,1,22.0,Gait disturbance,16201023
2,1,22.0,Ataxia,16201023
3,1,22.0,Cerebellar syndrome,16201023
4,1,22.0,Headache,16201023
5,1,22.0,Cerebellar ataxia,16201023
6,1,22.0,Neurotoxicity,16201023
7,1,22.0,Nausea,16201023
8,1,22.0,Fatigue,16201023
9,1,22.0,Slow speech,16201023
0,6,22.0,Delirium,16201027
1,6,22.0,Loss of personal independence in daily activities,16201027
0,6,22.0,Condition aggravated,16201028
1,6,22.0,Pleural effusion,16201028
2,6,22.0,Malignant pleural effusion,16201028
0,1,22.0,Nausea,16201030
1,2,22.0,Malaise,16201030
2,2,22.0,Stomatitis,16201030
0,5,22.0,Death,16201037
0,6,22.0,Off label use,16201111
0,6,22.0,Off label use,16201113
0,6,22.0,Off label use,16201118
0,3,22.0,Haemophagocytic lymphohistiocytosis,16201167
0,1,22.0,Neutrophil count decreased,16201184
0,1,22.1,Aortitis,16201186
0,6,22.0,Paronychia,16201208
1,6,22.0,Sunburn,16201208
2,6,22.0,Neutropenia,16201208
0,1,22.0,Hypotension,16201215
1,1,22.0,Hyperhidrosis,16201215
2,1,22.0,Hypertension,16201215
3,2,22.0,Hypersensitivity,16201215
4,1,22.0,Nausea,16201215
5,1,22.0,Erythema,16201215
0,2,22.0,Bone marrow failure,16201226
1,2,22.0,Cytopenia,16201226
2,2,22.0,Stomatitis,16201226
0,3,22.0,Nausea,16201233
1,3,22.0,Blood alkaline phosphatase increased,16201233
2,3,22.0,Haemoglobin decreased,16201233
3,3,22.0,Foot fracture,16201233
4,3,22.0,Decreased appetite,16201233
5,3,22.0,Abdominal distension,16201233
6,2,22.0,Peripheral swelling,16201233
7,3,22.0,Pancreatitis,16201233
8,3,22.0,Blood glucose decreased,16201233
9,3,22.0,Fatigue,16201233
0,2,22.0,Cyanosis,16201251
1,2,22.0,Loss of consciousness,16201251
2,2,22.0,Asthenia,16201251
3,2,22.0,Urinary incontinence,16201251
0,1,22.0,Back pain,16201293
0,1,22.0,Cholinergic syndrome,16201321
0,1,22.0,Acute generalised exanthematous pustulosis,16201325
1,1,22.0,Eyelid oedema,16201325
2,2,22.0,Photosensitivity reaction,16201325
3,2,22.0,Rash pustular,16201325
4,2,22.0,Skin lesion,16201325
5,2,22.0,Skin exfoliation,16201325
6,1,22.0,Pruritus,16201325
7,1,22.0,Erythema,16201325
0,3,22.0,Depression,16201328
1,3,22.0,Nausea,16201328
2,1,22.0,Neutrophil count decreased,16201328
3,3,22.0,Dysphagia,16201328
4,3,22.0,Pharyngitis,16201328
5,3,22.0,Hot flush,16201328
0,1,22.0,Weight increased,16201359
1,1,22.0,Haemorrhoids,16201359
2,2,22.0,Hot flush,16201359
3,1,22.0,Anal haemorrhage,16201359
0,1,22.0,Thrombosis,16201364
1,1,22.0,Haemorrhage,16201364
2,1,22.0,Hemiplegia,16201364
0,6,22.0,Drug resistance,16201382
0,6,22.0,Tooth disorder,16201386
1,6,22.0,Off label use,16201386
0,1,22.0,Small intestinal obstruction,16201389
1,1,22.0,Enteritis,16201389
0,,22.0,Hypertension,16201439
0,,22.0,Hospice care,16201441
1,,22.0,Therapy cessation,16201441
0,3,22.0,Small intestinal obstruction,16201442
0,,22.0,Metastases to bone,16201449
1,,22.0,Prostatic specific antigen increased,16201449
2,,22.0,Disease progression,16201449
0,,22.0,Death,16201454
0,6,22.0,Prostatic specific antigen abnormal,16201495
1,6,22.0,Blood testosterone increased,16201495
0,,22.0,Blood count abnormal,16201605
1,,22.0,Therapy cessation,16201605
0,6,22.0,Renal impairment,16201606
1,6,22.0,Bone marrow failure,16201606
2,6,22.0,Vomiting,16201606
3,6,22.0,Nausea,16201606
4,6,22.0,Transaminases increased,16201606
5,6,22.0,Neuropathy peripheral,16201606
0,1,22.0,Pulmonary embolism,16201612
0,,22.0,Death,16201613
0,6,22.0,Prostate cancer,16201614
1,3,22.0,Diplopia,16201614
0,,22.0,Cerebrovascular accident,16201625
0,3,22.0,Pneumonitis,16201670
1,1,22.0,Pneumonia bacterial,16201670
0,6,22.0,Enteritis,16201673
1,2,22.0,Hepatic function abnormal,16201673
2,1,22.0,Diarrhoea,16201673
3,1,22.0,Renal impairment,16201673
4,5,22.0,Cardiac failure congestive,16201673
5,3,22.0,Thrombocytopenia,16201673
6,6,22.0,Colitis,16201673
7,2,22.0,Anaemia,16201673
0,,22.0,Flushing,16201697
1,,22.0,Hot flush,16201697
0,3,22.0,Loss of personal independence in daily activities,16201703
1,3,22.0,Burning sensation,16201703
2,3,22.0,Hypersensitivity,16201703
3,3,22.0,Hypoaesthesia,16201703
4,6,22.0,C-reactive protein increased,16201703
5,3,22.0,Rash,16201703
6,3,22.0,Urticaria,16201703
7,3,22.0,Myalgia,16201703
8,3,22.0,Bone pain,16201703
9,3,22.0,Arthralgia,16201703
0,1,22.0,Hyponatraemia,16201734
1,3,22.0,Adrenal insufficiency,16201734
2,1,22.0,Diarrhoea,16201734
3,1,22.0,Dehydration,16201734
4,1,22.0,Vomiting,16201734
0,,22.0,Death,16201752
0,2,22.0,Organising pneumonia,16201774
1,2,22.0,Liver disorder,16201774
2,1,22.0,Sinus tachycardia,16201774
3,1,22.0,Decreased appetite,16201774
4,1,22.0,Supraventricular extrasystoles,16201774
0,,22.0,Death,16201793
0,,22.0,Dysphonia,16201839
0,,22.0,Small intestinal obstruction,16201840
0,5,22.0,Encephalopathy,16201847
1,6,22.0,Metastases to liver,16201847
2,5,22.0,Hepatic failure,16201847
3,5,22.0,Ascites,16201847
4,5,22.0,Discomfort,16201847
5,5,22.0,Somnolence,16201847
6,6,22.0,Cystatin C increased,16201847
7,6,22.0,Blood urea increased,16201847
8,5,22.0,Malignant neoplasm progression,16201847
9,5,22.0,Tremor,16201847
10,6,22.0,Neutrophil count decreased,16201847
11,5,22.0,Breast cancer,16201847
12,5,22.0,Jaundice,16201847
13,6,22.0,White blood cell count decreased,16201847
0,,22.0,Liver function test abnormal,16201858
1,,22.0,Blood bilirubin abnormal,16201858
0,1,22.0,Interstitial lung disease,16201866
0,6,22.0,Dyspnoea,16201884
1,6,22.0,Fatigue,16201884
2,6,22.0,Nasopharyngitis,16201884
3,6,22.0,Wheezing,16201884
0,1,22.0,Decreased appetite,16201918
1,1,22.0,Epistaxis,16201918
2,6,22.0,Neutrophil count decreased,16201918
3,1,22.0,Neutrophil count decreased,16201918
4,6,22.0,Neutrophil count decreased,16201918
5,6,22.0,Decreased appetite,16201918
6,6,22.0,Neutrophil count decreased,16201918
7,2,22.0,Anaemia,16201918
8,1,22.0,Constipation,16201918
9,1,22.0,Nausea,16201918
10,1,22.0,Aphonia,16201918
11,1,22.0,Fatigue,16201918
12,1,22.0,Asthenia,16201918
13,1,22.0,Epistaxis,16201918
14,1,22.0,Pruritus,16201918
15,1,22.0,Diarrhoea,16201918
16,6,22.0,Neutrophil count decreased,16201918
17,1,22.0,Hypertension,16201918
18,1,22.0,Hypertension,16201918
19,1,22.0,Blood alkaline phosphatase increased,16201918
0,1,22.0,Syncope,16201968
0,2,22.0,C-reactive protein increased,16201969
1,6,22.0,Abdominal pain,16201969
2,6,22.0,Anaemia macrocytic,16201969
3,1,22.0,Enterocolitis,16201969
4,6,22.0,Vitamin B12 deficiency,16201969
5,6,22.0,Diarrhoea,16201969
0,3,22.0,Neuropathy peripheral,16202009
1,6,22.0,Dizziness,16202009
2,3,22.0,Ejection fraction decreased,16202009
3,3,22.0,Tumour haemorrhage,16202009
4,6,22.0,Blood glucose decreased,16202009
5,6,22.0,Lymphoedema,16202009
0,2,22.0,Diarrhoea,16202019
1,6,22.0,Abdominal pain,16202019
2,6,22.0,Haematochezia,16202019
3,6,22.0,Intestinal haemorrhage,16202019
4,3,22.0,Constipation,16202019
5,6,22.0,Gastrointestinal wall thickening,16202019
6,6,22.0,Thyroid function test abnormal,16202019
0,3,22.0,Palmar-plantar erythrodysaesthesia syndrome,16202120
1,1,22.0,Osteonecrosis of jaw,16202120
0,6,22.0,Neoplasm malignant,16202143
1,4,22.0,Cerebral haemorrhage,16202143
2,6,22.0,Cerebral infarction,16202143
0,6,22.0,Hepatic neoplasm,16202162
1,6,22.0,Colon neoplasm,16202162
0,2,22.0,Alanine aminotransferase increased,16202172
1,2,22.0,Aspartate aminotransferase increased,16202172
2,6,22.0,Off label use,16202172
0,1,22.0,Erythema,16202179
1,1,22.0,Malaise,16202179
2,1,22.0,Hypersensitivity,16202179
3,1,22.0,Hypotension,16202179
4,1,22.0,Hypoxia,16202179
0,3,22.1,Pericardial effusion,16202197
1,3,22.1,Decreased appetite,16202197
0,3,22.0,Colon cancer metastatic,16202198
0,6,22.0,Anti-VGCC antibody positive,16202226
1,5,22.0,Starvation,16202226
2,6,22.0,Nervous system disorder,16202226
3,5,22.0,Dehydration,16202226
4,6,22.0,Encephalitis,16202226
5,3,22.0,Intestinal obstruction,16202226
0,6,22.0,Product use in unapproved indication,16202231
1,6,22.0,Immune system disorder,16202231
2,2,22.0,Decreased appetite,16202231
3,1,22.0,Pyrexia,16202231
0,6,22.0,Arthralgia,16202255
1,6,22.0,Nausea,16202255
2,6,22.0,Neuropathy peripheral,16202255
3,6,22.0,Myalgia,16202255
4,6,22.0,Bone pain,16202255
0,2,22.0,Radiation pneumonitis,16202369
0,2,22.0,Pancytopenia,16202370
0,4,22.0,Cerebrovascular accident,16202419
1,3,22.0,Feeling hot,16202419
2,3,22.0,Hyperhidrosis,16202419
3,3,22.0,Blood cholesterol increased,16202419
4,3,22.0,Feeling cold,16202419
5,1,22.0,Dysuria,16202419
6,1,22.0,Haemorrhage,16202419
0,3,22.1,Neoplasm progression,16202445
1,3,22.1,Asthenia,16202445
0,3,22.1,Hair texture abnormal,16202481
1,3,22.1,Hair colour changes,16202481
2,3,22.1,Hair disorder,16202481
3,3,22.1,Madarosis,16202481
4,3,22.1,Alopecia,16202481
0,3,22.0,Hair texture abnormal,16202485
1,3,22.0,Madarosis,16202485
2,3,22.0,Alopecia,16202485
3,3,22.0,Hair disorder,16202485
4,3,22.0,Hair colour changes,16202485
0,3,22.0,Neoplasm progression,16202585
0,6,22.0,Vomiting,16202621
1,6,22.0,Nausea,16202621
0,6,22.0,Urinary tract infection,16202624
0,3,22.0,Hair colour changes,16202628
1,3,22.0,Alopecia,16202628
2,3,22.0,Hair texture abnormal,16202628
3,3,22.0,Hair disorder,16202628
4,3,22.0,Madarosis,16202628
0,6,22.0,Poor quality product administered,16202638
1,6,22.0,Product physical issue,16202638
2,6,22.0,Rash,16202638
3,6,22.0,Infection,16202638
0,1,22.0,Enteritis,16202693
1,1,22.0,Small intestinal obstruction,16202693
0,6,22.1,Drug hypersensitivity,16202718
0,6,22.1,Tumour marker increased,16202725
0,6,22.0,Full blood count decreased,16202737
0,3,22.0,Hair texture abnormal,16202738
1,3,22.0,Madarosis,16202738
2,3,22.0,Alopecia,16202738
3,3,22.0,Hair disorder,16202738
4,3,22.0,Hair colour changes,16202738
0,3,22.0,Hair texture abnormal,16202744
1,3,22.0,Hair disorder,16202744
2,3,22.0,Madarosis,16202744
3,3,22.0,Alopecia,16202744
4,3,22.0,Hair colour changes,16202744
0,3,22.0,Hair colour changes,16202752
1,3,22.0,Alopecia,16202752
2,3,22.0,Hair texture abnormal,16202752
3,3,22.0,Madarosis,16202752
4,3,22.0,Hair disorder,16202752
0,6,22.0,Neoplasm progression,16202755
0,3,22.0,Alopecia,16202756
1,3,22.0,Hair colour changes,16202756
2,3,22.0,Hair texture abnormal,16202756
3,3,22.0,Hair disorder,16202756
4,3,22.0,Madarosis,16202756
0,1,22.0,Neutropenia,16202785
1,1,22.0,Acute kidney injury,16202785
2,1,22.0,Leukopenia,16202785
3,1,22.0,Thrombocytopenia,16202785
4,1,22.0,Pancytopenia,16202785
0,6,22.1,Leukopenia,16202798
1,2,22.1,Mucosal inflammation,16202798
2,1,22.1,Epistaxis,16202798
3,3,22.1,Neuropathy peripheral,16202798
4,1,22.1,Stomatitis,16202798
5,3,22.1,Fatigue,16202798
6,6,22.1,Product dispensing error,16202798
0,6,22.0,Cardiotoxicity,16202805
0,1,22.0,Haemorrhage subcutaneous,16202806
1,1,22.0,Generalised oedema,16202806
0,3,22.0,Bone pain,16202845
1,3,22.0,Vision blurred,16202845
2,3,22.0,Asthenia,16202845
3,3,22.0,Dizziness,16202845
4,3,22.0,Headache,16202845
5,3,22.0,Mental impairment,16202845
6,3,22.0,Fatigue,16202845
0,6,22.0,Mental disorder,16202847
1,3,22.0,Alopecia,16202847
0,3,22.0,Alopecia,16202849
1,3,22.0,Hair colour changes,16202849
2,3,22.0,Hair texture abnormal,16202849
3,3,22.0,Hair disorder,16202849
4,3,22.0,Madarosis,16202849
0,6,22.0,Neoplasm progression,16202850
1,6,22.0,Musculoskeletal chest pain,16202850
0,3,22.0,Hair texture abnormal,16202851
1,6,22.0,Depression,16202851
2,3,22.0,Hair disorder,16202851
3,6,22.0,Anxiety,16202851
4,3,22.0,Alopecia,16202851
5,3,22.0,Hair colour changes,16202851
0,3,22.0,Fatigue,16202858
1,3,22.0,Hyperhidrosis,16202858
2,3,22.0,Mood altered,16202858
3,6,22.0,Contraindicated product administered,16202858
4,3,22.0,Abnormal behaviour,16202858
0,1,22.0,Catheter site haemorrhage,16202901
0,1,22.0,Lactic acidosis,16202909
1,1,22.0,Diarrhoea,16202909
2,2,22.0,Dyspnoea,16202909
3,2,22.0,Acute kidney injury,16202909
0,1,22.0,Pyrexia,16202944
0,1,22.0,Neutropenia,16202959
1,1,22.0,Neutropenia,16202959
0,5,22.0,Leukaemic lymphoma,16202960
1,6,22.0,Off label use,16202960
2,5,22.0,Diffuse large B-cell lymphoma recurrent,16202960
3,5,22.0,Second primary malignancy,16202960
4,6,22.0,Product use in unapproved indication,16202960
0,6,22.0,Off label use,16202982
0,2,22.1,Malignant neoplasm progression,16202994
1,3,22.1,Asthenia,16202994
2,3,22.1,Diarrhoea,16202994
3,2,22.1,Fatigue,16202994
4,2,22.1,Odynophagia,16202994
5,3,22.1,Dry mouth,16202994
6,2,22.1,Dysphagia,16202994
7,1,22.1,Nausea,16202994
8,2,22.1,Faecaloma,16202994
9,2,22.1,Hypertension,16202994
10,3,22.1,Faeces discoloured,16202994
11,6,22.1,Cholecystitis infective,16202994
12,1,22.1,Feeling cold,16202994
13,1,22.1,Tremor,16202994
14,3,22.1,Dehydration,16202994
15,1,22.1,Abdominal pain,16202994
0,5,22.0,Cardio-respiratory arrest,16202999
1,3,22.0,Asthenia,16202999
2,5,22.0,Breast cancer metastatic,16202999
3,3,22.0,Dysarthria,16202999
4,3,22.0,Hallucination,16202999
0,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16203021
1,2,22.0,Headache,16203021
2,3,22.0,Taste disorder,16203021
3,6,22.0,Asthenia,16203021
4,3,22.0,Pain in extremity,16203021
5,3,22.0,Pneumonia,16203021
6,6,22.0,Stomatitis,16203021
7,3,22.0,Weight decreased,16203021
8,3,22.0,Dry skin,16203021
9,6,22.0,Decreased appetite,16203021
10,3,22.0,Oral pain,16203021
11,2,22.0,Weight increased,16203021
12,6,22.0,Myalgia,16203021
13,2,22.0,Fatigue,16203021
14,2,22.0,Increased appetite,16203021
15,3,22.0,Dysphonia,16203021
16,3,22.0,Arthralgia,16203021
17,3,22.0,Neck pain,16203021
0,6,22.0,Confusional state,16203039
1,6,22.0,Disorientation,16203039
2,6,22.0,Hallucination,16203039
3,6,22.0,Seizure,16203039
0,6,22.0,Spinal operation,16203052
0,6,22.0,Carbohydrate antigen 125 increased,16203057
1,6,22.0,Underdose,16203057
2,3,22.0,Product dose omission,16203057
3,6,22.0,Constipation,16203057
4,6,22.0,Gastrointestinal motility disorder,16203057
5,6,22.0,Recurrent cancer,16203057
6,6,22.0,Contusion,16203057
7,6,22.0,Memory impairment,16203057
0,6,22.0,Constipation,16203058
1,6,22.0,Vomiting,16203058
2,3,22.0,Platelet count decreased,16203058
3,6,22.0,White blood cell count decreased,16203058
4,6,22.0,Blood alkaline phosphatase increased,16203058
5,6,22.0,Drug ineffective,16203058
6,3,22.0,Recurrent cancer,16203058
7,3,22.0,Carbohydrate antigen 125 increased,16203058
8,6,22.0,Blood glucose increased,16203058
0,6,22.1,Haematuria,16203059
1,6,22.1,Balance disorder,16203059
2,3,22.1,Neuropathy peripheral,16203059
3,3,22.1,Tongue discolouration,16203059
4,6,22.1,Eye irritation,16203059
5,3,22.1,Insomnia,16203059
6,6,22.1,Weight decreased,16203059
7,6,22.1,Headache,16203059
8,6,22.1,Eating disorder,16203059
9,6,22.1,Asthenia,16203059
10,6,22.1,Disease progression,16203059
11,3,22.1,Decreased appetite,16203059
12,6,22.1,White blood cell count decreased,16203059
13,3,22.1,Pain,16203059
14,6,22.1,Stent placement,16203059
15,6,22.1,Drug intolerance,16203059
16,6,22.1,Pelvic mass,16203059
17,3,22.1,Constipation,16203059
18,3,22.1,Blood pressure increased,16203059
19,3,22.1,Fatigue,16203059
20,6,22.1,Dysuria,16203059
21,1,22.1,Nausea,16203059
0,1,22.0,Hyponatraemia,16203092
0,5,22.0,Interstitial lung disease,16203100
0,2,22.0,Generalised erythema,16203101
1,2,22.0,Anaphylactic shock,16203101
0,6,22.0,Drug interaction,16203102
1,1,22.0,Orgasm abnormal,16203102
0,5,22.0,Shock haemorrhagic,16203107
1,6,22.0,Epistaxis,16203107
2,5,22.0,Aortic perforation,16203107
3,6,22.0,Anastomotic ulcer,16203107
0,2,22.0,Parotitis,16203133
1,2,22.0,Anaphylactic shock,16203133
2,2,22.0,Generalised erythema,16203133
0,6,22.0,Non-cirrhotic portal hypertension,16203138
0,6,22.0,Splenomegaly,16203140
1,6,22.0,Varices oesophageal,16203140
0,5,22.0,Death,16203156
0,1,22.1,Anastomotic leak,16203221
0,1,22.0,Radiation pneumonitis,16203234
0,3,22.0,Bone pain,16203282
1,6,22.0,Tumour marker increased,16203282
2,3,22.0,Dyspepsia,16203282
3,6,22.0,Bone marrow failure,16203282
4,3,22.0,Fatigue,16203282
5,1,22.0,Platelet count decreased,16203282
6,3,22.0,White blood cell count decreased,16203282
0,3,22.0,Tremor,16203289
1,3,22.0,Neurotoxicity,16203289
0,1,22.0,Malignant neoplasm progression,16203460
1,1,22.0,Breast cancer metastatic,16203460
0,6,22.0,Acute kidney injury,16203469
1,6,22.0,General physical health deterioration,16203469
2,6,22.0,Prostate cancer metastatic,16203469
3,5,22.0,Sepsis,16203469
4,6,22.0,Hypotension,16203469
0,6,22.0,Brain neoplasm,16203557
1,6,22.0,Second primary malignancy,16203557
2,6,22.0,Endometriosis,16203557
3,6,22.0,Oestradiol abnormal,16203557
0,2,22.0,Diarrhoea,16203618
1,2,22.0,Haematochezia,16203618
2,2,22.0,Oesophageal haemorrhage,16203618
0,6,22.0,Pneumonia,16203628
1,6,22.0,Unresponsive to stimuli,16203628
2,6,22.0,Fatigue,16203628
3,6,22.0,Cellulitis,16203628
0,6,22.1,Cardiac failure congestive,16203629
0,1,22.0,Faecaloma,16203632
1,1,22.0,Neutropenia,16203632
0,1,22.0,Angina pectoris,16203704
1,6,22.0,Colon cancer,16203704
0,3,22.0,Palmar-plantar erythrodysaesthesia syndrome,16203705
1,,22.0,Off label use,16203705
2,,22.0,Temperature intolerance,16203705
3,,22.0,Nephrolithiasis,16203705
4,2,22.0,Fatigue,16203705
5,2,22.0,Lymphadenopathy,16203705
6,,22.0,Paraesthesia,16203705
7,,22.0,Exercise tolerance decreased,16203705
8,,22.0,Hepatic enzyme increased,16203705
9,3,22.0,Alopecia,16203705
10,,22.0,Limb discomfort,16203705
11,,22.0,Neuropathy peripheral,16203705
12,1,22.0,Nausea,16203705
13,,22.0,Dysphonia,16203705
0,2,22.0,Sleep disorder,16203706
1,6,22.0,Blood chloride decreased,16203706
2,6,22.0,Musculoskeletal pain,16203706
3,1,22.0,Platelet count decreased,16203706
4,6,22.0,Haematocrit decreased,16203706
5,6,22.0,Therapeutic response unexpected,16203706
6,6,22.0,Neck pain,16203706
7,6,22.0,Blood urea increased,16203706
8,3,22.0,Blood creatinine increased,16203706
9,1,22.0,Blood pressure increased,16203706
10,1,22.0,Dehydration,16203706
11,1,22.0,Condition aggravated,16203706
12,1,22.0,Muscle spasms,16203706
13,6,22.0,Blood sodium decreased,16203706
14,6,22.0,Blood urine present,16203706
15,3,22.0,Fatigue,16203706
16,1,22.0,Haemoglobin decreased,16203706
17,6,22.0,Head discomfort,16203706
18,1,22.0,Nausea,16203706
19,1,22.0,Decreased appetite,16203706
20,6,22.0,Underdose,16203706
21,3,22.0,Drug intolerance,16203706
22,1,22.0,Dizziness,16203706
23,6,22.0,Musculoskeletal discomfort,16203706
24,1,22.0,Blood sodium decreased,16203706
25,6,22.0,Haemoglobin decreased,16203706
26,3,22.0,Asthenia,16203706
0,4,22.0,Squamous cell carcinoma of skin,16203708
1,4,22.0,Second primary malignancy,16203708
2,4,22.0,Second primary malignancy,16203708
3,4,22.0,Squamous cell carcinoma,16203708
4,1,22.0,Squamous cell carcinoma of skin,16203708
5,1,22.0,Second primary malignancy,16203708
0,2,22.0,Pneumonia legionella,16203728
0,6,22.1,Interstitial lung disease,16203763
0,1,22.0,Vomiting,16203768
1,1,22.0,Diarrhoea,16203768
2,1,22.0,Dehydration,16203768
0,3,22.0,Constipation,16203781
1,3,22.0,Decreased appetite,16203781
2,3,22.0,Neuropathy peripheral,16203781
0,6,22.0,Blood disorder,16203832
0,5,22.0,Rectal haemorrhage,16203877
1,5,22.0,Duodenal ulcer,16203877
0,6,22.0,Prostate cancer metastatic,16203897
1,6,22.0,Platelet count decreased,16203897
2,6,22.0,Drug ineffective,16203897
0,1,22.0,Guillain-Barre syndrome,16203975
0,6,22.0,Headache,16203999
1,1,22.0,Vocal cord cyst,16203999
2,6,22.0,Epistaxis,16203999
0,3,22.0,Alopecia,16204022
0,2,22.0,Bone marrow failure,16204130
1,6,22.0,Malaise,16204130
2,1,22.0,Nausea,16204130
3,6,22.0,Nasal dryness,16204130
0,5,22.0,Malignant neoplasm progression,16204172
0,1,22.0,Blood pressure abnormal,16204200
1,2,22.0,Vomiting,16204200
2,2,22.0,Nausea,16204200
3,2,22.0,Dizziness,16204200
0,6,22.0,Osteonecrosis of jaw,16204213
1,6,22.0,Fistula,16204213
0,2,22.0,Haemorrhage intracranial,16204253
1,3,22.0,Product use in unapproved indication,16204253
0,1,22.0,Pneumonitis,16204278
0,1,22.0,Acute kidney injury,16204284
0,1,22.0,Tachycardia,16204312
1,1,22.0,Erythema,16204312
2,1,22.0,Dyspnoea,16204312
3,1,22.0,Pruritus,16204312
0,2,22.0,Hyperkalaemia,16204321
1,5,22.0,Death,16204321
2,2,22.0,Renal impairment,16204321
0,5,22.0,Death,16204322
1,6,22.0,Mucosal inflammation,16204322
2,2,22.0,Erythema multiforme,16204322
3,2,22.0,Pneumonitis,16204322
0,6,22.0,Diarrhoea,16204330
1,1,22.0,Neuropathy peripheral,16204330
2,1,22.0,Pulmonary cavitation,16204330
3,6,22.0,Malignant pleural effusion,16204330
0,5,22.0,Mucosal inflammation,16204342
1,5,22.0,Pancytopenia,16204342
2,5,22.0,Multiple organ dysfunction syndrome,16204342
3,1,22.0,Labelled drug-drug interaction medication error,16204342
0,2,22.1,Lung disorder,16204357
1,2,22.1,Acute respiratory distress syndrome,16204357
2,6,22.1,Respiratory failure,16204357
3,2,22.1,Pneumonia aspiration,16204357
4,6,22.1,Liver disorder,16204357
5,6,22.1,Pleural effusion,16204357
0,4,22.0,Radiation pneumonitis,16204366
0,1,22.0,Rash pruritic,16204374
1,1,22.0,Dyspnoea,16204374
2,1,22.0,Lip oedema,16204374
0,6,22.0,Bladder cancer recurrent,16204378
1,3,22.0,Bladder cancer recurrent,16204378
0,2,22.0,Renal impairment,16204383
1,2,22.0,Vomiting,16204383
2,6,22.0,Ascites,16204383
3,2,22.0,Dehydration,16204383
4,6,22.0,Concomitant disease aggravated,16204383
5,5,22.0,Death,16204383
0,2,22.1,Electrolyte imbalance,16204385
1,1,22.1,Inappropriate antidiuretic hormone secretion,16204385
2,1,22.1,General physical health deterioration,16204385
0,6,22.0,Blood pressure decreased,16204404
1,5,22.0,Chronic obstructive pulmonary disease,16204404
2,5,22.0,Pyrexia,16204404
3,5,22.0,Small cell lung cancer extensive stage,16204404
4,5,22.0,Asthenia,16204404
5,5,22.0,Malaise,16204404
6,6,22.0,Urine output decreased,16204404
7,5,22.0,Dyspnoea,16204404
0,1,22.1,Hypertension,16204419
1,1,22.1,Neuralgia,16204419
0,,22.0,Hormone-refractory prostate cancer,16204441
1,2,22.0,Compression fracture,16204441
0,6,22.0,Febrile neutropenia,16204474
1,6,22.0,Neutropenia,16204474
0,2,22.0,Retinopathy,16204493
0,6,22.1,Therapeutic response unexpected,16204495
1,2,22.1,Blood count abnormal,16204495
2,3,22.1,Headache,16204495
3,2,22.1,Granulocyte count decreased,16204495
4,2,22.1,White blood cell count decreased,16204495
0,6,22.0,Neoplasm progression,16204496
0,6,22.1,Carcinoembryonic antigen increased,16204554
1,6,22.1,Carbohydrate antigen 15-3 increased,16204554
0,3,22.0,Hepatocellular injury,16204557
1,3,22.0,Cholestasis,16204557
0,1,22.1,Cholecystitis,16204586
0,6,22.0,Breast cancer metastatic,16204630
1,6,22.0,Malignant neoplasm progression,16204630
0,3,22.0,Mouth ulceration,16204631
1,5,22.0,Toxicity to various agents,16204631
2,3,22.0,Fatigue,16204631
3,3,22.0,Pyrexia,16204631
4,3,22.0,Neutropenia,16204631
5,5,22.0,Neutropenic sepsis,16204631
6,3,22.0,Mucosal inflammation,16204631
7,3,22.0,Colitis,16204631
8,3,22.0,Dyspnoea,16204631
0,6,22.0,Atelectasis,16204634
1,4,22.0,Pleural effusion,16204634
2,6,22.0,Dyspnoea,16204634
0,6,22.0,Thrombocytopenia,16204686
0,6,22.0,Pyrexia,16204692
0,6,22.0,Liver function test increased,16204693
0,1,22.0,Dizziness,16204701
1,1,22.0,Metastases to bone,16204701
2,1,22.0,Breast cancer,16204701
3,1,22.0,Metastases to lymph nodes,16204701
4,1,22.0,Fatigue,16204701
5,6,22.0,Dyspnoea,16204701
6,1,22.0,Metastases to the mediastinum,16204701
7,1,22.0,Metastases to lung,16204701
8,1,22.0,Hydrothorax,16204701
9,1,22.0,Hypertension,16204701
10,1,22.0,Leiomyoma,16204701
11,1,22.0,Metastases to pleura,16204701
12,6,22.0,Pleural effusion,16204701
0,6,22.0,Metastases to central nervous system,16204730
1,1,22.0,Metastases to eye,16204730
2,1,22.0,Diabetes mellitus,16204730
3,1,22.0,Hypertension,16204730
4,1,22.0,Hypercholesterolaemia,16204730
0,6,22.0,Hyperventilation,16204734
1,6,22.0,Anxiety,16204734
2,6,22.0,Cough,16204734
3,6,22.0,Pneumonitis,16204734
4,6,22.0,Respiratory rate increased,16204734
5,6,22.0,Sneezing,16204734
6,6,22.0,Asthma,16204734
7,6,22.0,Wheezing,16204734
8,6,22.0,Fatigue,16204734
9,6,22.0,Pleural effusion,16204734
10,6,22.0,Pyrexia,16204734
11,6,22.0,Respiratory failure,16204734
12,6,22.0,Crepitations,16204734
13,6,22.0,Malaise,16204734
14,6,22.0,Dyspnoea,16204734
0,6,22.0,Diarrhoea,16204781
1,6,22.0,Abdominal distension,16204781
2,6,22.0,Generalised oedema,16204781
3,6,22.0,Peripheral swelling,16204781
4,6,22.0,Headache,16204781
5,1,22.0,Mouth swelling,16204781
6,1,22.0,Nausea,16204781
7,6,22.0,Lip swelling,16204781
8,1,22.0,Swelling face,16204781
0,3,22.0,Acute myeloid leukaemia,16204821
1,3,22.0,Second primary malignancy,16204821
0,6,22.0,Flushing,16204824
1,1,22.0,Hyperpyrexia,16204824
0,6,22.0,Diarrhoea,16204828
1,6,22.0,Pain,16204828
0,6,22.0,Tumour haemorrhage,16204831
1,6,22.0,Neutrophil count decreased,16204831
0,5,22.1,Death,16204833
0,6,22.0,Neoplasm progression,16205001
0,1,22.0,Fatigue,16205032
1,1,22.0,Eye swelling,16205032
2,1,22.0,Conjunctival hyperaemia,16205032
3,1,22.0,Headache,16205032
0,5,22.1,Death,16205096
1,6,22.1,Intentional product use issue,16205096
0,5,22.0,Autoimmune haemolytic anaemia,16205111
1,6,22.0,Reticulocyte count increased,16205111
2,3,22.0,Platelet count decreased,16205111
3,6,22.0,Immune thrombocytopenic purpura,16205111
0,5,22.0,Death,16205127
1,6,22.0,Intentional product use issue,16205127
0,2,22.0,Oral pain,16205143
1,2,22.0,Dry skin,16205143
2,2,22.0,Haematology test abnormal,16205143
3,1,22.0,Malignant neoplasm progression,16205143
4,1,22.0,Breast cancer metastatic,16205143
0,5,22.0,Death,16205159
0,6,22.0,Ascites,16205169
1,1,22.0,Abdominal distension,16205169
0,6,22.0,C-reactive protein increased,16205201
1,3,22.0,Atrial fibrillation,16205201
2,2,22.0,Pleural effusion,16205201
0,1,22.0,Arthralgia,16205203
1,1,22.0,Fatigue,16205203
2,1,22.0,Anaemia,16205203
3,1,22.0,Back pain,16205203
0,6,22.1,Urine output decreased,16205218
1,2,22.1,Prescribed overdose,16205218
2,2,22.1,Product prescribing error,16205218
3,2,22.1,Acute kidney injury,16205218
4,2,22.1,Hyperkalaemia,16205218
5,2,22.1,Sinus arrest,16205218
6,2,22.1,Rhythm idioventricular,16205218
0,6,22.0,Pleurisy,16205271
0,1,22.0,Ventricular arrhythmia,16205277
1,3,22.0,Bradycardia,16205277
2,1,22.0,Cardiac failure,16205277
3,3,22.0,Pericardial effusion,16205277
4,1,22.0,Aspartate aminotransferase increased,16205277
5,6,22.0,Blood lactate dehydrogenase increased,16205277
0,1,22.0,Febrile neutropenia,16205279
0,1,22.0,Nausea,16205305
1,1,22.0,Stomatitis,16205305
2,1,22.0,Urinary tract infection,16205305
3,1,22.0,Abscess,16205305
4,3,22.0,Dry skin,16205305
5,1,22.0,Epistaxis,16205305
6,3,22.0,Visual impairment,16205305
7,1,22.0,Peripheral sensory neuropathy,16205305
8,3,22.0,Bone pain,16205305
9,1,22.0,Erythema multiforme,16205305
10,1,22.0,Myalgia,16205305
11,1,22.0,Alopecia,16205305
12,3,22.0,Diarrhoea,16205305
13,3,22.0,Fatigue,16205305
14,1,22.0,Chills,16205305
15,1,22.0,Skin disorder,16205305
16,1,22.0,Rash pustular,16205305
0,2,22.0,Immune thrombocytopenic purpura,16205315
0,6,22.0,Spinal cord neoplasm,16205345
1,6,22.0,Paraparesis,16205345
2,6,22.0,Osteonecrosis of jaw,16205345
3,5,22.0,Disease progression,16205345
4,6,22.0,Facial paresis,16205345
0,5,22.0,Cardiac death,16205374
0,1,22.0,Feeling hot,16205394
1,1,22.0,Oxygen saturation decreased,16205394
2,1,22.0,Dyspnoea,16205394
0,6,22.0,Neutropenia,16205396
1,6,22.0,Gastrointestinal toxicity,16205396
2,6,22.0,Skin toxicity,16205396
3,6,22.0,Haematotoxicity,16205396
0,3,22.0,Rash,16205398
1,3,22.0,Alopecia,16205398
0,6,22.0,Enterocolitis,16205422
1,5,22.0,Death,16205422
0,6,22.0,Vomiting,16205451
1,6,22.0,Bone marrow failure,16205451
2,6,22.0,Neurotoxicity,16205451
0,6,22.0,Neutrophil count decreased,16205515
1,6,22.0,Platelet count decreased,16205515
2,6,22.0,Gastrointestinal disorder,16205515
3,6,22.0,Haemoglobin decreased,16205515
4,6,22.0,Liver injury,16205515
0,6,22.0,Leukopenia,16205521
1,6,22.0,Cholecystitis chronic,16205521
2,6,22.0,Nausea,16205521
3,6,22.0,Vomiting,16205521
0,6,22.0,Respiratory failure,16205522
1,1,22.0,Pneumonitis,16205522
0,5,22.0,Death,16205535
0,5,22.0,Death,16205562
0,3,22.0,Prostatic specific antigen increased,16205601
1,3,22.0,Bronchitis,16205601
2,3,22.0,Dizziness,16205601
3,3,22.0,Vision blurred,16205601
4,3,22.0,Gait disturbance,16205601
5,3,22.0,Hypoaesthesia,16205601
6,3,22.0,Headache,16205601
0,6,22.0,Red blood cell count decreased,16205617
1,6,22.0,White blood cell count decreased,16205617
0,6,22.0,Dyspnoea,16205678
1,6,22.0,Pneumonitis,16205678
2,6,22.0,Cough,16205678
0,6,22.0,Cancer pain,16205699
0,5,22.0,Malaise,16205799
1,5,22.0,Sepsis,16205799
0,1,22.0,Antibiotic level above therapeutic,16205818
1,1,22.0,Rash,16205818
2,1,22.0,Pneumonia,16205818
3,1,22.0,Acute kidney injury,16205818
0,1,22.0,Hyperhidrosis,16205874
1,1,22.0,Fatigue,16205874
2,1,22.0,Blood pressure increased,16205874
3,6,22.0,Metastases to liver,16205874
4,1,22.0,Hot flush,16205874
0,6,22.0,Nausea,16205897
1,6,22.0,Wound dehiscence,16205897
2,6,22.0,Abscess,16205897
3,6,22.0,Enterocutaneous fistula,16205897
4,6,22.0,Anaemia,16205897
5,6,22.0,Leukopenia,16205897
6,6,22.0,Anastomotic complication,16205897
7,6,22.0,Toxicity to various agents,16205897
8,6,22.0,Diarrhoea,16205897
9,6,22.0,Vomiting,16205897
10,6,22.0,Radiation skin injury,16205897
11,6,22.0,Thrombocytopenia,16205897
12,6,22.0,Abdominal pain,16205897
13,6,22.0,Dysuria,16205897
0,3,22.0,Tooth fracture,16205908
0,6,22.0,Malignant neoplasm progression,16205931
0,2,22.0,Angina pectoris,16205948
1,2,22.0,Thrombocytopenia,16205948
2,2,22.0,Neuralgia,16205948
3,2,22.0,Nausea,16205948
0,1,22.0,Dehydration,16206046
1,1,22.0,Shock,16206046
2,1,22.0,Lactic acidosis,16206046
3,2,22.0,Acute kidney injury,16206046
4,1,22.0,Hyperkalaemia,16206046
5,1,22.0,Coma,16206046
6,1,22.0,Vomiting,16206046
7,1,22.0,Diarrhoea,16206046
0,,22.0,Fatigue,16206087
1,,22.0,Therapy change,16206087
0,,22.0,Myocardial infarction,16206092
1,,22.0,Loss of consciousness,16206092
0,6,22.0,Leukopenia,16206097
1,6,22.0,Cough,16206097
2,6,22.0,Hepatocellular injury,16206097
3,6,22.0,Neutropenia,16206097
4,1,22.0,Postmenopausal haemorrhage,16206097
5,1,22.0,Anaemia,16206097
6,6,22.0,Dysuria,16206097
7,6,22.0,Bilirubin conjugated increased,16206097
8,1,22.0,Neuropathy peripheral,16206097
9,3,22.0,Gamma-glutamyltransferase increased,16206097
10,1,22.0,Paraesthesia,16206097
11,3,22.0,Blood alkaline phosphatase increased,16206097
12,6,22.0,Aspartate aminotransferase increased,16206097
13,3,22.0,Leukocytosis,16206097
14,6,22.0,Genital infection,16206097
15,6,22.0,Pyrexia,16206097
16,6,22.0,Vision blurred,16206097
17,6,22.0,Vertigo,16206097
18,3,22.0,Neutrophilia,16206097
19,3,22.0,Hyperglycaemia,16206097
20,6,22.0,Rhinorrhoea,16206097
21,1,22.0,Blood lactate dehydrogenase increased,16206097
22,1,22.0,Platelet count decreased,16206097
23,3,22.0,Alanine aminotransferase increased,16206097
24,6,22.0,Respiratory disorder,16206097
0,1,22.0,Dehydration,16206099
1,1,22.0,Renal failure,16206099
2,1,22.0,Diarrhoea,16206099
0,6,22.0,Radiation pneumonitis,16206103
1,1,22.0,Dyspnoea,16206103
2,6,22.0,Pneumonitis,16206103
0,6,22.0,Haemoglobin decreased,16206111
1,5,22.0,Death,16206111
0,3,22.0,Neuropathy peripheral,16206118
0,6,22.0,Abdominal distension,16206129
1,6,22.0,Abdominal pain,16206129
2,5,22.0,Death,16206129
3,6,22.0,Ascites,16206129
4,6,22.0,Decreased appetite,16206129
5,6,22.0,Subileus,16206129
0,1,22.1,Artery dissection,16206136
0,6,22.0,Abdominal operation,16206137
0,2,22.0,Headache,16206152
1,2,22.0,Pruritus generalised,16206152
2,2,22.0,Hyperhidrosis,16206152
3,2,22.0,Suffocation feeling,16206152
4,2,22.0,Vomiting,16206152
5,2,22.0,Hypotension,16206152
0,6,22.0,Tubulointerstitial nephritis,16206164
1,6,22.0,Mesangioproliferative glomerulonephritis,16206164
0,,22.0,Death,16206169
0,3,22.0,Arthritis,16206246
0,,22.0,Disease progression,16206264
1,,22.0,Laboratory test abnormal,16206264
0,,22.0,Disease progression,16206268
0,2,22.0,Biopsy lung abnormal,16206279
1,2,22.0,Multifocal micronodular pneumocyte hyperplasia,16206279
2,2,22.0,Organising pneumonia,16206279
3,2,22.0,Therapeutic response decreased,16206279
4,2,22.0,Computerised tomogram thorax abnormal,16206279
5,2,22.0,Pulmonary oedema,16206279
6,2,22.0,Bronchial polyp,16206279
7,2,22.0,Hypoxia,16206279
8,2,22.0,Product use in unapproved indication,16206279
9,2,22.0,Respiratory failure,16206279
0,1,22.0,Bone marrow failure,16206324
0,,22.0,Death,16206329
0,,22.0,Death,16206339
0,6,22.0,Transaminases increased,16206351
0,5,22.0,Adverse event,16206364
0,5,22.0,Thrombosis,16206392
1,5,22.0,Lymphoma,16206392
2,5,22.0,Neuropathy peripheral,16206392
3,5,22.0,Pneumonia,16206392
0,6,22.0,Electrocardiogram QT prolonged,16206402
1,6,22.0,Therapy partial responder,16206402
2,6,22.0,Blood creatinine increased,16206402
3,6,22.0,Enterococcal bacteraemia,16206402
4,6,22.0,Febrile neutropenia,16206402
5,6,22.0,Hypocalcaemia,16206402
6,6,22.0,Oedema peripheral,16206402
7,6,22.0,Fatigue,16206402
8,6,22.0,Blood parathyroid hormone increased,16206402
0,,22.0,Disease progression,16206407
0,6,22.0,Feeling cold,16206425
1,6,22.0,Chest pain,16206425
2,6,22.0,Dizziness,16206425
0,4,22.0,Diarrhoea,16206431
0,6,22.0,Neuropathy peripheral,16206432
1,6,22.0,Ill-defined disorder,16206432
2,6,22.0,Pyrexia,16206432
3,6,22.0,Skin burning sensation,16206432
4,6,22.0,Loss of personal independence in daily activities,16206432
5,6,22.0,Immunodeficiency,16206432
6,6,22.0,Asthenia,16206432
0,,22.0,Product dose omission,16206445
1,,22.0,Fatigue,16206445
0,,22.0,Death,16206459
0,6,22.0,Buttock injury,16206465
1,6,22.0,Apparent death,16206465
2,6,22.0,Skin ulcer,16206465
3,3,22.0,Abdominal symptom,16206465
4,6,22.0,Gastric cancer,16206465
0,,22.0,Cough,16206471
1,,22.0,Throat tightness,16206471
2,,22.0,Post procedural complication,16206471
0,6,22.0,Product dose omission,16206571
1,3,22.0,Malaise,16206571
2,3,22.0,Bone pain,16206571
3,3,22.0,Fatigue,16206571
0,6,22.0,Transient ischaemic attack,16206574
0,2,22.0,Trigeminal neuralgia,16206576
0,2,22.0,Sinus node dysfunction,16206591
0,6,22.0,Tendon rupture,16206618
0,6,22.1,Seizure,16206690
1,6,22.1,Neoplasm progression,16206690
2,6,22.1,Condition aggravated,16206690
3,6,22.1,Breast mass,16206690
0,5,22.0,Delirium,16206735
1,6,22.0,Mental status changes,16206735
2,6,22.0,Sepsis,16206735
3,6,22.0,Pyrexia,16206735
0,4,22.0,Pelvic fracture,16206744
0,1,22.0,Intestinal perforation,16206756
0,6,22.0,Alanine aminotransferase increased,16206782
1,6,22.0,Bilirubin conjugated increased,16206782
2,6,22.0,Blood bilirubin increased,16206782
3,6,22.0,White blood cell count decreased,16206782
4,6,22.0,Ascites,16206782
5,6,22.0,Gamma-glutamyltransferase increased,16206782
6,6,22.0,Blood albumin decreased,16206782
7,6,22.0,Neutrophil count decreased,16206782
8,6,22.0,Aspartate aminotransferase increased,16206782
9,6,22.0,Discomfort,16206782
10,6,22.0,Cystatin C increased,16206782
11,6,22.0,Encephalopathy,16206782
12,6,22.0,Tremor,16206782
13,6,22.0,Blood urea increased,16206782
14,6,22.0,Blood creatinine increased,16206782
15,6,22.0,Somnolence,16206782
16,6,22.0,Jaundice,16206782
17,5,22.0,Hepatic failure,16206782
18,6,22.0,Blood alkaline phosphatase increased,16206782
0,6,22.0,Invasive ductal breast carcinoma,16206807
0,5,22.0,Respiratory disorder,16206830
0,1,22.0,Constipation,16206873
1,1,22.0,Headache,16206873
2,6,22.0,Decreased appetite,16206873
3,6,22.0,Fatigue,16206873
4,3,22.0,Nausea,16206873
5,6,22.0,Product dose omission,16206873
6,3,22.0,Neuropathy peripheral,16206873
0,1,22.0,Oedema peripheral,16206898
1,1,22.0,Lichenoid keratosis,16206898
0,6,22.0,Hepatic cancer recurrent,16206905
0,3,22.0,Nausea,16206908
1,6,22.0,Nervousness,16206908
2,1,22.0,Urinary tract infection,16206908
3,3,22.0,Red blood cell count decreased,16206908
4,6,22.0,Glucose urine present,16206908
5,6,22.0,Seasonal allergy,16206908
6,6,22.0,Full blood count decreased,16206908
7,3,22.0,Insomnia,16206908
8,6,22.0,Neuropathy peripheral,16206908
9,6,22.0,Memory impairment,16206908
10,6,22.0,Glycosylated haemoglobin increased,16206908
11,6,22.0,Somnolence,16206908
12,3,22.0,Constipation,16206908
13,2,22.0,Dyspnoea,16206908
14,6,22.0,Confusional state,16206908
15,6,22.0,Feeling abnormal,16206908
16,6,22.0,Rhinorrhoea,16206908
17,6,22.0,Alopecia,16206908
18,6,22.0,Laboratory test abnormal,16206908
19,2,22.0,Fatigue,16206908
20,6,22.0,Back pain,16206908
0,6,22.0,Thrombocytopenia,16206914
0,6,22.0,Renal disorder,16206918
1,6,22.0,Diarrhoea,16206918
2,6,22.0,Renal impairment,16206918
3,6,22.0,Movement disorder,16206918
0,3,22.0,Carbohydrate antigen 125 increased,16206941
1,6,22.0,White blood cell count decreased,16206941
2,3,22.0,Urinary tract infection,16206941
3,3,22.0,Blood creatinine increased,16206941
0,3,22.0,Diarrhoea,16206952
1,3,22.0,Decreased appetite,16206952
2,3,22.0,Hot flush,16206952
3,3,22.0,Fatigue,16206952
0,1,22.0,Skin cancer,16206953
0,1,22.0,Diarrhoea,16206971
1,1,22.0,Prerenal failure,16206971
0,6,22.0,Lymphangiosis carcinomatosa,16207009
1,6,22.0,Malignant pleural effusion,16207009
2,6,22.0,Malignant neoplasm progression,16207009
3,6,22.0,Anaemia,16207009
0,6,22.0,Abdominal pain,16207053
1,6,22.0,Anal incontinence,16207053
2,6,22.0,Diarrhoea,16207053
3,6,22.0,Proctalgia,16207053
4,6,22.0,Proctitis,16207053
5,6,22.0,Toxicity to various agents,16207053
6,6,22.0,Cystitis,16207053
7,6,22.0,Gastrointestinal toxicity,16207053
8,6,22.0,Dermatitis,16207053
0,5,22.0,Death,16207068
0,5,22.0,Interstitial lung disease,16207123
0,6,22.0,Malignant neoplasm progression,16207130
1,6,22.0,Metastases to bone,16207130
0,6,22.0,Sleep apnoea syndrome,16207131
1,6,22.0,Fatigue,16207131
2,6,22.0,Dysphagia,16207131
3,6,22.0,Anxiety,16207131
4,6,22.0,Dyspnoea,16207131
5,2,22.0,Decreased appetite,16207131
6,6,22.0,Pulmonary embolism,16207131
7,6,22.0,Insomnia,16207131
8,6,22.0,Adverse event,16207131
9,6,22.0,Delirium,16207131
10,6,22.0,Urinary retention,16207131
11,6,22.0,Somnolence,16207131
12,2,22.0,Depression,16207131
13,6,22.0,Constipation,16207131
14,6,22.0,Vomiting,16207131
15,6,22.0,Cognitive disorder,16207131
0,2,22.0,Ascites,16207150
0,6,22.0,Adverse event,16207236
1,6,22.0,Inappropriate schedule of product administration,16207236
0,2,22.0,Rhabdomyolysis,16207237
1,,22.0,Muscular weakness,16207237
2,2,22.0,Thrombocytopenia,16207237
3,2,22.0,Neutropenia,16207237
4,2,22.0,Asthenia,16207237
0,3,22.0,Hot flush,16207252
1,3,22.0,Hair disorder,16207252
2,3,22.0,Fatigue,16207252
3,3,22.0,Weight increased,16207252
4,6,22.0,Stomatitis,16207252
5,3,22.0,Asthenia,16207252
6,6,22.0,Ankle fracture,16207252
7,6,22.0,Gastrointestinal disorder,16207252
0,5,22.0,Death,16207257
1,6,22.0,Off label use,16207257
0,5,22.0,Malignant neoplasm progression,16207278
0,1,22.0,Thrombocytopenia,16207307
1,1,22.0,Respiratory tract haemorrhage,16207307
2,3,22.0,General physical health deterioration,16207307
3,1,22.0,Respiratory tract haemorrhage,16207307
0,1,22.0,Anaemia,16207314
1,1,22.0,Liver abscess,16207314
0,3,22.0,Radiation pneumonitis,16207318
1,6,22.0,Metastases to liver,16207318
0,5,22.0,Glioma,16207362
0,5,22.0,Death,16207367
0,6,22.0,Inappropriate schedule of product administration,16207373
1,1,22.0,Neutrophil count decreased,16207373
2,1,22.0,Platelet count decreased,16207373
3,1,22.0,Anaemia,16207373
0,5,22.0,Malignant neoplasm progression,16207403
1,5,22.0,Sepsis,16207403
2,5,22.0,Pneumonia,16207403
0,3,22.0,Fatigue,16207417
1,3,22.0,Blood magnesium decreased,16207417
2,3,22.0,Arthralgia,16207417
3,6,22.0,Product use in unapproved indication,16207417
4,3,22.0,Sleep disorder,16207417
5,3,22.0,Peripheral swelling,16207417
6,6,22.0,Drug effective for unapproved indication,16207417
0,6,22.0,Breast cancer,16207428
0,1,22.0,Rectal haemorrhage,16207431
0,6,22.0,Hypotension,16207443
1,6,22.0,Neuropathy peripheral,16207443
2,6,22.0,Fatigue,16207443
3,6,22.0,Epistaxis,16207443
4,6,22.0,Thrombosis,16207443
5,6,22.0,Malaise,16207443
0,6,22.0,Neoplasm progression,16207449
0,6,22.0,Neutropenia,16207450
1,6,22.0,Weight increased,16207450
2,3,22.0,White blood cell count decreased,16207450
3,6,22.0,Pyrexia,16207450
4,6,22.0,Product dose omission,16207450
5,6,22.0,Malaise,16207450
6,6,22.0,Fatigue,16207450
7,3,22.0,Neutrophil count decreased,16207450
8,6,22.0,Rash,16207450
9,6,22.0,Pruritus,16207450
0,5,22.0,Death,16207535
0,2,22.0,Hepatic function abnormal,16207546
1,2,22.0,Radiation pneumonitis,16207546
2,1,22.0,Eosinophil count increased,16207546
3,2,22.0,Decreased appetite,16207546
0,6,22.0,Cough,16207554
1,2,22.0,Diarrhoea,16207554
0,6,22.1,Emotional disorder,16207599
1,6,22.1,Dyspnoea,16207599
2,6,22.1,Paranoia,16207599
3,6,22.1,Middle insomnia,16207599
4,2,22.1,Weight decreased,16207599
5,6,22.1,Blood count abnormal,16207599
6,6,22.1,Arthralgia,16207599
7,6,22.1,Mean cell volume increased,16207599
8,6,22.1,Diarrhoea,16207599
9,6,22.1,Nausea,16207599
10,6,22.1,Pain in extremity,16207599
11,6,22.1,Abdominal discomfort,16207599
12,6,22.1,Neoplasm progression,16207599
13,6,22.1,Fatigue,16207599
14,6,22.1,Anxiety,16207599
15,6,22.1,Influenza,16207599
16,6,22.1,Alopecia,16207599
17,6,22.1,Cognitive disorder,16207599
18,6,22.1,Insomnia,16207599
19,6,22.1,Nervousness,16207599
0,6,22.0,Drug ineffective for unapproved indication,16207603
0,6,22.1,Neoplasm progression,16207619
1,6,22.1,Platelet count decreased,16207619
2,6,22.1,Neutropenia,16207619
3,6,22.1,Nausea,16207619
0,6,22.0,Cognitive disorder,16207624
1,6,22.0,Pain,16207624
0,6,22.1,Asthenia,16207628
1,6,22.1,Constipation,16207628
2,6,22.1,Neoplasm progression,16207628
3,3,22.1,Fatigue,16207628
4,3,22.1,Pain,16207628
5,6,22.1,Dehydration,16207628
0,6,22.0,Drug ineffective for unapproved indication,16207634
0,5,22.0,Rectal cancer,16207635
0,1,22.0,Tachycardia,16207801
1,1,22.0,Hypersensitivity,16207801
2,1,22.0,Dyspnoea,16207801
3,1,22.0,Bronchospasm,16207801
4,1,22.0,Malaise,16207801
5,1,22.0,Hypertension,16207801
6,1,22.0,Erythema,16207801
0,6,22.0,Pneumonia bacterial,16207819
1,6,22.0,Asthenia,16207819
2,6,22.0,Malnutrition,16207819
3,6,22.0,Metabolic acidosis,16207819
4,6,22.0,Rhabdomyolysis,16207819
5,6,22.0,Metabolic encephalopathy,16207819
6,6,22.0,Hyperkalaemia,16207819
7,6,22.0,Ischaemic cerebral infarction,16207819
8,5,22.0,Malignant neoplasm progression,16207819
9,6,22.0,Dehydration,16207819
10,6,22.0,Septic shock,16207819
11,6,22.0,Acute kidney injury,16207819
12,6,22.0,Hypophagia,16207819
13,6,22.0,Respiratory failure,16207819
14,6,22.0,Leukopenia,16207819
0,6,22.0,Pulmonary oedema,16207820
1,2,22.0,Tuberculosis,16207820
0,6,22.0,Nausea,16207839
1,6,22.0,Vomiting,16207839
2,6,22.0,Diarrhoea,16207839
0,6,22.0,Rectal haemorrhage,16207840
1,6,22.0,Neoplasm progression,16207840
0,1,22.1,Erythema multiforme,16207852
1,6,22.1,Diabetes mellitus,16207852
2,6,22.1,Pigmentation disorder,16207852
3,1,22.1,Pyrexia,16207852
4,2,22.1,Myocardial infarction,16207852
5,1,22.1,Interstitial lung disease,16207852
0,6,22.0,Intentional product use issue,16207879
1,6,22.0,Hepatic cyst,16207879
2,6,22.0,Haemangioma of liver,16207879
3,6,22.0,Off label use,16207879
0,3,22.0,Dry mouth,16207885
1,6,22.0,Product use in unapproved indication,16207885
0,6,22.0,Acute myeloid leukaemia,16207888
1,6,22.0,Nausea,16207888
2,6,22.0,Pyrexia,16207888
3,6,22.0,Second primary malignancy,16207888
4,6,22.0,Cough,16207888
5,6,22.0,Malaise,16207888
0,6,22.0,Diarrhoea,16207897
1,6,22.0,Abdominal discomfort,16207897
2,6,22.0,Abdominal pain upper,16207897
3,3,22.0,Arthralgia,16207897
0,3,22.0,Hair colour changes,16207931
1,3,22.0,Madarosis,16207931
2,3,22.0,Alopecia,16207931
3,3,22.0,Hair disorder,16207931
4,3,22.0,Hair texture abnormal,16207931
0,6,22.0,Drug hypersensitivity,16207935
0,6,22.0,Alopecia,16207944
1,6,22.0,Chills,16207944
2,6,22.0,Nausea,16207944
3,6,22.0,Fatigue,16207944
0,6,22.0,Hypoaesthesia,16207981
1,6,22.0,Diverticulitis,16207981
0,1,22.1,Hepatic function abnormal,16207988
0,6,22.0,Anaemia,16207995
0,6,22.0,Tubulointerstitial nephritis,16208045
1,6,22.0,Microangiopathy,16208045
0,5,22.0,Death,16208048
0,5,22.0,Fall,16208057
0,3,22.0,End stage renal disease,16208093
0,6,22.0,Leukopenia,16208094
0,,22.0,Rash,16208111
1,5,22.0,Death,16208111
2,,22.0,Off label use,16208111
3,1,22.0,Hyperpyrexia,16208111
4,,22.0,Lung infection,16208111
0,6,22.0,Fracture,16208118
0,3,22.0,White blood cell count decreased,16208126
1,3,22.0,Peripheral swelling,16208126
2,3,22.0,Joint swelling,16208126
3,,22.0,Weight increased,16208126
4,3,22.0,Red blood cell count decreased,16208126
5,3,22.0,Haemoglobin decreased,16208126
0,,22.0,Renal impairment,16208149
0,2,22.0,Oedema peripheral,16208159
1,2,22.0,Drug-induced liver injury,16208159
2,2,22.0,Thyroid disorder,16208159
3,,22.0,Dyspnoea exertional,16208159
4,2,22.0,Abnormal weight gain,16208159
5,,22.0,Pleural effusion,16208159
6,2,22.0,Hepatic enzyme increased,16208159
0,,22.0,Colon cancer,16208163
1,6,22.0,Carbohydrate antigen 19-9 increased,16208163
2,6,22.0,Carcinoembryonic antigen increased,16208163
0,6,22.0,Blood iron decreased,16208166
1,6,22.0,Fatigue,16208166
2,6,22.0,Skin fissures,16208166
3,6,22.0,Erythema,16208166
0,,22.0,Sepsis,16208169
1,,22.0,Product use in unapproved indication,16208169
2,,22.0,Pneumonia,16208169
3,,22.0,Off label use,16208169
0,6,22.0,Colitis ischaemic,16208193
0,2,22.0,Ascites,16208246
0,2,22.0,Blood pressure increased,16208252
1,2,22.0,Chest discomfort,16208252
2,2,22.0,Hypoaesthesia,16208252
3,2,22.0,Hyperventilation,16208252
4,2,22.0,Vomiting,16208252
5,2,22.0,Tachypnoea,16208252
6,2,22.0,Tachycardia,16208252
0,1,22.0,Electrolyte imbalance,16208261
1,2,22.0,Transverse sinus thrombosis,16208261
2,1,22.0,Renal tubular disorder,16208261
0,1,22.0,Leiomyoma,16208262
0,6,22.0,Genital haemorrhage,16208324
1,6,22.0,Platelet count decreased,16208324
2,6,22.0,Epistaxis,16208324
0,5,22.0,Death,16208354
1,6,22.0,Vomiting,16208354
0,2,22.0,Flatulence,16208388
1,6,22.0,Increased appetite,16208388
2,1,22.0,Constipation,16208388
3,6,22.0,Haemoglobin decreased,16208388
4,6,22.0,Terminal state,16208388
5,1,22.0,Abdominal pain,16208388
6,3,22.0,Platelet count decreased,16208388
7,6,22.0,Splenomegaly,16208388
8,6,22.0,Back pain,16208388
9,5,22.0,Death,16208388
10,6,22.0,Weight increased,16208388
11,6,22.0,Pain,16208388
12,6,22.0,Acne,16208388
13,6,22.0,Asthenia,16208388
14,1,22.0,Insomnia,16208388
15,6,22.0,Therapeutic response unexpected,16208388
16,1,22.0,Urinary tract infection,16208388
0,6,22.0,Blood pressure abnormal,16208390
1,6,22.0,Asthenia,16208390
2,6,22.0,Anaemia,16208390
3,6,22.0,Hypotonia,16208390
0,6,22.0,Leukopenia,16208469
1,6,22.0,Vomiting,16208469
2,6,22.0,Nausea,16208469
3,6,22.0,Metastasis,16208469
0,6,22.0,Neuropathy peripheral,16208487
0,1,22.0,Dehydration,16208494
1,1,22.0,Diarrhoea,16208494
2,1,22.0,Hyperkalaemia,16208494
3,1,22.0,Coma,16208494
4,1,22.0,Vomiting,16208494
5,1,22.0,Lactic acidosis,16208494
6,1,22.0,Shock,16208494
7,2,22.0,Acute kidney injury,16208494
0,1,22.0,Product dose omission,16208507
0,6,22.0,Off label use,16208518
1,5,22.0,Metastases to liver,16208518
2,6,22.0,Ascites,16208518
3,5,22.0,Malignant neoplasm progression,16208518
4,6,22.0,Product use in unapproved indication,16208518
0,6,22.0,Fatigue,16208520
1,6,22.0,Somnolence,16208520
2,1,22.0,Oral pain,16208520
3,6,22.0,Nasopharyngitis,16208520
4,6,22.0,White blood cell count decreased,16208520
0,5,22.0,Death,16208521
0,3,22.0,Hyporeflexia,16208535
1,3,22.0,Dermatitis acneiform,16208535
2,3,22.0,Muscle contractions involuntary,16208535
3,3,22.0,Paraesthesia,16208535
4,3,22.0,Asthenia,16208535
0,3,22.0,Acute myeloid leukaemia,16208542
0,2,22.0,Blood potassium decreased,16208547
1,2,22.0,Blood magnesium decreased,16208547
2,2,22.0,Prothrombin time prolonged,16208547
3,2,22.0,Asthenia,16208547
4,1,22.0,Neutropenia,16208547
5,2,22.0,Blood phosphorus decreased,16208547
6,2,22.0,Alanine aminotransferase increased,16208547
7,2,22.0,Aspartate aminotransferase increased,16208547
8,2,22.0,Hypoalbuminaemia,16208547
9,6,22.0,Diarrhoea,16208547
10,6,22.0,Thrombocytopenia,16208547
0,6,22.0,Swelling,16208552
1,6,22.0,Fatigue,16208552
2,6,22.0,Cough,16208552
3,6,22.0,Pain,16208552
4,6,22.0,Blindness,16208552
5,6,22.0,Blood glucose fluctuation,16208552
6,6,22.0,Nasopharyngitis,16208552
7,6,22.0,Underdose,16208552
8,6,22.0,Blood glucose increased,16208552
9,6,22.0,Amnesia,16208552
10,6,22.0,Increased appetite,16208552
11,6,22.0,Bronchitis,16208552
0,5,22.0,Acute respiratory distress syndrome,16208556
0,4,22.0,Type 2 diabetes mellitus,16208570
0,6,22.0,Leukopenia,16208571
0,6,22.0,Breast cancer metastatic,16208575
1,6,22.0,Disease progression,16208575
0,6,22.0,Gastrointestinal obstruction,16208596
0,6,22.0,Cerebral ischaemia,16208598
0,,22.0,Dry skin,16208642
1,2,22.0,Blood bilirubin increased,16208642
2,,22.0,Pain in extremity,16208642
3,3,22.0,Dyspnoea,16208642
4,,22.0,Dysphonia,16208642
5,3,22.0,Headache,16208642
6,1,22.0,Oral pain,16208642
7,3,22.0,Fatigue,16208642
8,2,22.0,Asthenia,16208642
9,3,22.0,Neuropathy peripheral,16208642
10,,22.0,Off label use,16208642
0,1,22.1,Myocarditis,16208646
1,1,22.1,Sepsis,16208646
0,5,22.0,Staphylococcus test positive,16208649
1,5,22.0,Pyrexia,16208649
2,5,22.0,Interstitial lung disease,16208649
3,5,22.0,Malignant neoplasm progression,16208649
4,5,22.0,Cerebral artery thrombosis,16208649
5,5,22.0,Brain oedema,16208649
6,5,22.0,Idiopathic pulmonary fibrosis,16208649
7,5,22.0,Subendocardial ischaemia,16208649
8,5,22.0,Arteriosclerosis,16208649
9,5,22.0,Interstitial lung disease,16208649
0,6,22.0,Neutropenia,16208708
0,6,22.0,Skin exfoliation,16208715
0,3,22.0,Arthritis,16208779
0,1,22.0,Lichenoid keratosis,16208799
1,1,22.0,Oedema peripheral,16208799
0,2,22.0,Diarrhoea,16208833
1,1,22.0,Sepsis,16208833
2,1,22.0,Leukopenia,16208833
0,6,22.0,Malignant neoplasm progression,16208848
0,6,22.0,Dry skin,16208852
1,6,22.0,Fatigue,16208852
2,1,22.0,Thrombosis,16208852
3,2,22.0,Pneumonia,16208852
4,6,22.0,Diarrhoea,16208852
0,6,22.0,White blood cell count decreased,16208853
1,6,22.0,Red blood cell count decreased,16208853
2,3,22.0,Nausea,16208853
0,2,22.0,Alopecia,16208856
0,2,22.0,Alopecia,16208864
0,2,22.0,Alopecia,16208871
0,2,22.1,Alopecia,16208894
0,2,22.1,Alopecia,16208900
1,6,22.1,Psychological trauma,16208900
0,1,22.0,Influenza,16209065
1,2,22.0,Negativism,16209065
2,3,22.0,Unevaluable event,16209065
0,3,22.0,Arthritis,16209114
0,2,22.0,Febrile neutropenia,16209181
0,6,22.0,Osteonecrosis,16209197
0,3,22.0,Bronchiectasis,16209258
0,1,22.0,Hepatic function abnormal,16209281
0,1,22.0,Cachexia,16209314
0,1,22.0,Pyelonephritis,16209315
0,1,22.0,Pneumonitis,16209321
0,6,22.0,Drug intolerance,16209331
0,4,22.0,Prinzmetal angina,16209374
1,1,22.0,Chest discomfort,16209374
2,1,22.0,Dyspnoea,16209374
0,3,22.0,Aphasia,16209376
1,3,22.0,Malaise,16209376
2,3,22.0,Weight decreased,16209376
3,2,22.0,Oesophageal stenosis,16209376
4,3,22.0,Pneumonia,16209376
0,2,22.0,Chronic obstructive pulmonary disease,16209377
0,5,22.0,Malignant neoplasm progression,16209394
1,6,22.0,Interstitial lung disease,16209394
0,6,22.1,Blood potassium decreased,16209421
1,1,22.1,Myocarditis,16209421
2,1,22.1,Sepsis,16209421
0,3,22.0,Enterocolitis,16209424
1,5,22.0,Malignant neoplasm progression,16209424
2,3,22.0,Superior vena cava syndrome,16209424
0,5,22.0,Respiratory failure,16209436
1,6,22.0,Pulmonary embolism,16209436
2,5,22.0,Neoplasm progression,16209436
